Detalles de la búsqueda
1.
ENABLE-SG (Educate, Nurture, Advise, Before Life Ends for Singapore) as a proactive palliative care model: protocol for a hybrid type 1 effectiveness-implementation randomized wait-list controlled trial.
BMC Palliat Care
; 23(1): 29, 2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287335
2.
Early Triple-Negative Breast Cancers in a Singapore Cohort Exhibit High PIK3CA Mutation Rates Associated With Low PD-L1 Expression.
Mod Pathol
; 36(4): 100056, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788078
3.
Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer.
Breast Cancer Res Treat
; 193(1): 121-138, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35262831
4.
Integrating immunotherapy in the (neo)adjuvant setting of early breast cancer.
Curr Opin Oncol
; 32(6): 575-584, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852307
5.
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer.
Clin Cancer Res
; 30(7): 1240-1247, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236575
6.
External validation of the first prognostic nomogram for older adults with cancer.
Ther Adv Med Oncol
; 15: 17588359231198433, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37786539
7.
Carcinoma of unknown primary site.
N Engl J Med
; 371(21): 2039, 2014 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25409387
8.
Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody-drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore.
Expert Opin Drug Metab Toxicol
; 18(12): 805-815, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636012
9.
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies.
Ther Adv Med Oncol
; 14: 17588359221087555, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35432603
10.
A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma.
Nat Commun
; 13(1): 6453, 2022 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36307410
11.
Candida Endophthalmitis Treated Successfully With Isavuconazole: A Case Report.
Open Forum Infect Dis
; 8(12): ofab516, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34909437
12.
First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas.
J Immunother Cancer
; 9(8)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389618
13.
Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden.
Nat Commun
; 12(1): 2229, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33850132
14.
Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer.
Sci Adv
; 7(41): eabh2443, 2021 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34613780
15.
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience.
JCO Precis Oncol
; 52021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250396
16.
Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer.
Front Oncol
; 11: 698551, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34336686
17.
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC.
J Thorac Oncol
; 15(12): 1928-1934, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32866654
18.
Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond.
Ther Adv Med Oncol
; 11: 1758835919880429, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31636720
19.
Are There Any Clinically Relevant Subgroups of Triple-Negative Breast Cancer in 2018?
J Oncol Pract
; 14(5): 281-289, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29746805
20.
What is the role of immunotherapy in breast cancer?
Chin Clin Oncol
; 7(2): 13, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29764158